Diabetic Foot & Ankle
Volume 9, 2018 - Issue 1
Open access
1,550
Views
6
CrossRef citations to date
0
Altmetric
Trend Article
Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers
Martin Romero PradaPublic Health in Fundacion Salutia, Center in Health Economics Investigator, Bogotá D.C., ColombiaCorrespondence[email protected]
http://orcid.org/0000-0001-6158-6090View further author information
, http://orcid.org/0000-0001-6158-6090View further author information
Carolina RoaPublic Health in Fundacion Salutia, Center in Health Economics Investigator, Bogotá D.C., ColombiaView further author information
, Pamela AlfonsoPublic Health in Fundacion Salutia, Center in Health Economics Investigator, Bogotá D.C., ColombiaView further author information
, German AceroPublic Health in Fundacion Salutia, Center in Health Economics Investigator, Bogotá D.C., ColombiaView further author information
, Lina HuérfanoPublic Health in Fundacion Salutia, Center in Health Economics Investigator, Bogotá D.C., ColombiaView further author information
& David Vivas-ConsueloHealth Economics and management, Universitat Politècnica de València (UPV), Valencia, Españahttp://orcid.org/0000-0003-2945-7525View further author information
Article: 1480249
|
Received 07 Nov 2017, Accepted 16 May 2018, Published online: 26 Jun 2018
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.